Update shared on04 Sep 2025
As both the discount rate (8.90%) and net profit margin (15.41%) for Rockwell Automation remained unchanged, the consensus analyst price target was maintained at $350.50.
What's in the News
- Rockwell Automation completed a buyback tranche, repurchasing 473,929 shares for $122.9 million, totaling 34.75 million shares repurchased under the program.
- Raised fiscal 2025 guidance, with expected sales midpoint at ~$8.2 billion (up from ~$8.1 billion) and diluted EPS of $8.89–$9.29 (up from $8.23–$9.23).
- Released PointMax I/O, a modular, scalable remote input/output system designed to improve flexibility, scalability, and integration for complex manufacturing environments.
- Sintetica SA adopted Rockwell's FactoryTalk PharmaSuite MES to drive digital transformation, improve operational insights, and accelerate batch reviews.
- Expanded ROKStudios video series with content highlighting industrial leaders' use of AI and digital technologies, emphasizing automation's role in supply chain resilience, operational efficiency, and collaborative human-machine innovation.
Valuation Changes
Summary of Valuation Changes for Rockwell Automation
- The Consensus Analyst Price Target remained effectively unchanged, at $350.50.
- The Discount Rate for Rockwell Automation remained effectively unchanged, at 8.90%.
- The Net Profit Margin for Rockwell Automation remained effectively unchanged, at 15.41%.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.